Maryland State Retirement & Pension System Reduces Stake in DaVita Inc. $DVA

Maryland State Retirement & Pension System trimmed its stake in DaVita Inc. (NYSE:DVA) by 15.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,859 shares of the company’s stock after selling 344 shares during the quarter. Maryland State Retirement & Pension System’s holdings in DaVita were worth $265,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. National Pension Service boosted its stake in DaVita by 74.3% in the first quarter. National Pension Service now owns 197 shares of the company’s stock valued at $30,000 after acquiring an additional 84 shares during the last quarter. Y.D. More Investments Ltd purchased a new position in DaVita in the first quarter valued at about $35,000. Ameritas Advisory Services LLC purchased a new position in DaVita in the second quarter valued at about $47,000. NewEdge Advisors LLC lifted its stake in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after buying an additional 88 shares in the last quarter. Finally, University of Texas Texas AM Investment Management Co. purchased a new stake in shares of DaVita during the 1st quarter valued at approximately $83,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently commented on DVA shares. Wall Street Zen cut shares of DaVita from a “buy” rating to a “hold” rating in a research note on Saturday. Truist Financial set a $140.00 price target on shares of DaVita in a research note on Tuesday. Barclays dropped their price target on shares of DaVita from $160.00 to $149.00 and set an “equal weight” rating on the stock in a research note on Thursday, October 9th. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a research note on Wednesday, October 8th. Finally, Bank of America dropped their price target on shares of DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a research note on Wednesday, September 10th. Four equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, DaVita presently has an average rating of “Reduce” and an average price target of $153.25.

DaVita Price Performance

Shares of NYSE:DVA opened at $126.53 on Wednesday. The company’s fifty day moving average price is $132.66 and its 200-day moving average price is $138.88. The firm has a market capitalization of $9.05 billion, a price-to-earnings ratio of 12.44, a PEG ratio of 0.89 and a beta of 1.13. DaVita Inc. has a one year low of $122.93 and a one year high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $2.70 by $0.25. The firm had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The business’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Insider Activity at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider owned 26,038 shares of the company’s stock, valued at approximately $3,905,700. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.50% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.